Cyclooxygenase-2 inhibitors in human skeletal fracture healing

Area of Science:

• Orthopedics
• Molecular Biology
• Immunology

Background:

• Fracture nonunion, a failure of bone healing, affects a subset of patients.
• The molecular mechanisms underlying fracture nonunion are not fully understood.
• Cyclooxygenase-2 (COX-2) plays a role in bone healing and inflammation.

Purpose of the Study:

• To identify molecular events contributing to fracture nonunion.
• To investigate the role of COX-2 and immune response in fracture healing.
• To evaluate the impact of COX-2 inhibition on osteogenesis.

Main Methods:

• Gene expression profiling of fracture callus tissue from patients with uneventful repair and nonunion.
• In vitro experiments using Saos-2 osteoprogenitor cell lines.
• Treatment of cell lines with celecoxib, a selective COX-2 inhibitor.

Main Results:

• Nonunion fractures exhibited decreased COX-2 expression compared to uneventful healing.
• Fracture callus in nonunion cases showed an impaired immune response.
• Celecoxib treatment reduced osteogenic potential in Saos-2 cells, indicating impaired bone formation.

Conclusions:

• An initial immune response is critical for successful fracture healing.
• Reduced COX-2 expression and immune response are associated with fracture nonunion.
• Limited use of COX-2 inhibitors is recommended in patients with healing fractures to avoid compromising bone repair.